SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 323 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,678,000 | +25.5% | 11,046 | -1.5% | 0.00% | +33.3% |
| Q1 2019 | $1,337,000 | +9.5% | 11,215 | +0.2% | 0.00% | -25.0% |
| Q4 2018 | $1,221,000 | -23.4% | 11,191 | +13.4% | 0.00% | 0.0% |
| Q3 2018 | $1,594,000 | +27.5% | 9,871 | +4.4% | 0.00% | +33.3% |
| Q2 2018 | $1,250,000 | +78.6% | 9,454 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $700,000 | +209.7% | 9,454 | -44.4% | 0.00% | +100.0% |
| Q1 2015 | $226,000 | -63.7% | 16,990 | -60.5% | 0.00% | -50.0% |
| Q4 2014 | $623,000 | -31.4% | 43,030 | 0.0% | 0.00% | -33.3% |
| Q3 2014 | $908,000 | -29.2% | 43,030 | 0.0% | 0.00% | -40.0% |
| Q2 2014 | $1,282,000 | +24.0% | 43,030 | 0.0% | 0.01% | +25.0% |
| Q1 2014 | $1,034,000 | +71.8% | 43,030 | +45.7% | 0.00% | +100.0% |
| Q4 2013 | $602,000 | -56.8% | 29,530 | 0.0% | 0.00% | -66.7% |
| Q3 2013 | $1,395,000 | +48.9% | 29,530 | +19.9% | 0.01% | +50.0% |
| Q2 2013 | $937,000 | – | 24,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |